Edgewise Therapeutics Inc. Common Stock vs Figma Inc. Class A Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while Figma Inc. Class A Common Stock trades at $21.24 (market cap $11.60B). The key difference: Figma Inc. Class A Common Stock is far larger — about 2.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Figma Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Figma Inc. Class A Common Stock for 0 Days on average.
| EWTX | FIG | |
|---|---|---|
Market Cap | $3.94B | $11.60B |
Volume | 810,104 | 12,281,013 |
Sector | Health | Technology |
52-Week High | $48.35 | $63.82 |
52-Week Low | $14.89 | $16.84 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $10.00B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →